Second Measles Case Confirmed In Lowell, Possible Exposure In Chelmsford, Tewksbury
LOWELL (CBS) – A second case of measles has been diagnosed in Lowell and there may have been exposure to that person in Chelmsford and Tewksbury, state health officials confirmed Saturday. The latest case was discovered at the Lowell Community Health Center on Thursday, November 15, seven days after a two-year-old boy came down with the measles there. No information was released about the second person. “The individual was present in a number of locations that could have resulted in exposures to other people,” the Massachusetts Department of Public Health said in a statement. “There are no known links between the two cases,” said State Epidemiologist Dr. Catherine Brown. “Our efforts now are to identify people who may be at risk of getting ill and to get them vaccinated. Getting vaccinated within 3-5 days of an exposure can reduce the likelihood of getting measles.” DPH said exposures to the second person may have occurred at: T.J. Maxx, 288 Chelmsford St., Chelmsford Sunday November 11, 2018 3:00 p.m. – 7:00 p.m. Lowell Community Health Center, 161 Jackson St., Lowell Thursday November 15, 2018 4:00 p.m. – 9:00 p.m. Walmart Supercenter, 333 Main St., Tewksbury Thursday November 15, 2018 5:00 p.m. – 8:00 p.m. Anyone who was exposed at those locations during those times should call their doctor to confirm their immunization status. If you develop symptoms of measles, call before you visit an office, clinic, or e...
Publication date: April 2020Source: Current Opinion in Virology, Volume 41Author(s): Peter J Hotez, Tasmiah Nuzhath, Brian Colwell
Patients became infected while visiting Italy and Tenerife Related items fromOnMedica Going Viral Measles claims 140,000 lives as cases surge worldwide Four further UK nationals test positive for COVID-19 Vaccination better than antivirals in beating flu G8 must tackle health inequality, says Bill Gates and WHO
CONCLUSIONSWe confirm that seroprotection for vaccine-preventable disease is affected by treatment for pediatric malignancy. A single booster dose of vaccine might be a practical way to restore vaccine immunity in patients after chemotherapy.
‘Extra assessment and better training needed’ Related items fromOnMedica Under-fives must play more and spend less time sitting with screens Should we have compulsory measles vaccination at school entry? Swine flu jab in pregnancy safe for children as well as mothers Pay more heed to parent concern over sick children Women with small babies can safely wait for labour
UK CMOs raise risk from ‘low’ to ‘moderate’ Related items fromOnMedica Going Viral Measles claims 140,000 lives as cases surge worldwide Vaccination better than antivirals in beating flu G8 must tackle health inequality, says Bill Gates and WHO Chief medical officer to step down in September
Luke Gardner, 21, from Northamptonshire, is well aware of the toll the illness can take. He caught mumps as well as German measles while studying broadcast journalism.
Jäger Ungerechts Engeland Priming and activation of CD8+ T cell responses is crucial to achieve anti-viral and anti-tumor immunity. Live attenuated measles vaccine strains have been used successfully for immunization for decades and are currently investigated in trials of oncolytic virotherapy. The available reverse genetics systems allow for insertion of additional genes, including heterologous antigens. Here, we designed recombinant measles vaccine vectors for priming and activation of antigen-specific CD8+ T cells. For proof-of-concept, we used cytotoxic T lymphocyte (CTL) lines specific for the melano...
TTP, a technology company based in Melbourn, UK, is developing a handheld PCR (polymerase chain reaction) diagnostic device that can rapidly detect influenza viruses, and one day other viruses, in samples of nasal mucus. The company claims that the s...
Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science 2019;366:599-606.
Measles may lead to serious, fatal complications not often associated with the disease, a new study finds.